LC-MS Profiling of Nucleotide Pools

Nucleotides degrade in minutes, and the standard workflow takes longer.

The Degradation Problem

AnalyteStability at room temperatureDegradation route
ATPMinutesPhosphatase hydrolysis to ADP, AMP, adenosine
ADP, AMPMinutesContinued hydrolysis
dNTPMinutesHydrolysis; also cell-cycle dependent
NAD⁺Minutes to hoursGlycohydrolase; pH dependent
GTP, CTP, UTPMinutesHydrolysis

Important distinction. The degradation products are themselves nucleotides in the panel. A slow extraction therefore does not merely lower the values — it redistributes them, converting ATP into ADP and AMP and changing the energy charge it appears to measure. The artefact is systematic and it mimics a biological state.

Part 1 — Quench and Extract

StepRecommendationWhy
Medium removalRapid aspiration, or direct quench on the plateWashing takes time; cells continue metabolising
QuenchIce-cold 0.5–1 M perchloric acid, or cold 80% methanol with 0.1 M formic acidStops enzyme activity immediately
Time from medium removal to quenchUnder 30 secondsThe dominant determinant of the result
ExtractionIce, sonication or freeze–thaw cyclesComplete release from cells
NeutralisationAmmonium bicarbonate or potassium hydroxide, on icePerchloric acid must be removed before LC-MS
Centrifugation4 °C, to remove protein and saltPrecipitate interferes with injection
InjectionImmediately, or store at −80 °CStorage changes the profile

The third row is the single most important operational variable in this protocol. Two laboratories with identical chromatography and different harvest times will report different energy charges from the same cells.

Part 2 — Chromatography

ApproachSuitsNote
Ion-pairing reverse phase (e.g. tributylamine, HFBA)NTP, dNTP, sugar nucleotidesExcellent separation; ion-pair reagent contaminates the instrument
HILICNucleotides, some cofactorsGood for polar analytes; peak shape sensitive to pH
Porous graphitic carbonNucleotidesRobust; long equilibration
Reverse phase with derivatisationSelected analytesMore work; better specificity for some

Readout note. Nucleotides are small, highly charged and chemically similar, so separation rather than detection is the limiting step. A method that resolves ATP from dATP, or GDP from dGDP, is what allows the deoxy and ribo pools to be reported separately; without that resolution, the two are one peak.

Part 3 — Normalisation

BasisAppropriate whenCaveat
Cell numberProliferation is not the variableCounting accuracy at low cell numbers
Total proteinRoutineProtein changes with treatment
Cell volumeComparing concentrationsVolume measurement is indirect
Internal standard (isotope-labelled ATP)Absolute quantificationCorrects recovery, not degradation before quench
Total phosphate or total metabolite sumMetabolomics-style comparisonsAssumes the sum is stable

Important distinction. An isotope-labelled internal standard added at the extraction step corrects for losses during processing, but it does not correct for degradation that occurred before the standard was added. That is why the quench time matters more than the standard.

Part 4 — What the Profile Can Support

ClaimRequiresNot sufficient
"ATP fell"Quenched, calibrated measurement with recoveryA relative fold-change from a slow extraction
"dNTP pool fell"Separate dNTP measurementTotal nucleotide or ATP
"Synthesis increased"Labelled precursor incorporationPool size
"Energy charge changed"ATP, ADP and AMP measured togetherATP alone
"Antimetabolite engaged its target"Target metabolite change plus downstream effectDrug response alone

Part 5 — Common Failures

  • • Harvest taking minutes, so the profile reports degradation.
  • • Medium not removed, so extracellular nucleotides contaminate the measurement.
  • • Washing with warm buffer, which allows metabolism to continue.
  • • Perchloric acid not neutralised or removed, damaging the column and suppressing ionisation.
  • • Reverse phase without ion-pairing, giving poor retention and peak shape.
  • • Total nucleotide reported as dNTP.
  • • Repeated freeze–thaw of extracts.
  • • Normalisation to protein in treatments that change protein content.
  • • No internal standard, so recovery is unknown.

Part 6 — Where This Article Connects

This is the analytical companion to the nucleotide metabolism article, which covers the routes and the antimetabolite logic. It connects to the one-carbon tracing article, since labelled formate and glycine are measured in the same nucleotide pool, and to the serine article, which supplies the glycine and formate.

If you need nucleotide pools measured with rapid quenching and dNTP resolution, we can scope the analysis with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Nucleotide pools, degradation rates and extraction recovery vary by cell type, matrix and method; recovery and quench time must be established for the specific protocol.

A pool size does not establish a synthesis rate, and ATP does not report the deoxyribonucleotide pools that limit replication.

Scientific interpretation and experimental design

  • • Quench time dominates. Under 30 seconds.
  • • Degradation redistributes, not only lowers.
  • • Remove medium first. Extracellular nucleotides contaminate.
  • • Internal standard corrects processing, not pre-quench loss.
  • • Resolve deoxy from ribo. They are different pools.
  • • ATP is not dNTP.

Selected references for further reading

  • • Lane AN, et al. Rapid and reliable quantitation of amino acids and nucleotides by LC-MS/MS. Journal of Chromatography B. 2019;1125:121713.
  • • Lu W, et al. Analytical strategies for LC-MS-based targeted metabolomics. Journal of Chromatography B. 2008;871:236–242.
  • • Bennett BD, et al. Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli. Nature Chemical Biology. 2009;5:593–599.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: